Results 21 to 30 of about 4,456,525 (155)

Proton Beam Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma [PDF]

International Journal of Particle Therapy, 2023
Purpose: To discuss the role of proton beam therapy (PBT) in the treatment of patients with oropharyngeal squamous cell carcinoma (OPSCC). Materials and Methods: A review of the pertinent literature. Results: Proton beam therapy likely results in reduced
William M. Mendenhall, MD, Jonathan J. Beitler, MD, MBA, Nabil F. Saba, MD, FACP, Ashok R. Shaha, MD, FACS, Sandra Nuyts, MD, PhD, Primož Strojan, MD, Heleen Bollen, MD, Oded Cohen, MD, Robert Smee, MD, Sweet Ping Ng, MD, Avraham Eisbruch, MD, Wai Tong Ng, MD, Jessica M. Kirwan, MA, Alfio Ferlito, MD, DLO, DPath, FRCSEd ad hominem, FRCS (Eng, Glasg, Ir) ad eundem, FDSRCS ad eundem, FACS, FHKCORL, FRCPath, FASCP, IFCAP   +13 more
doaj   +1 more source

Clinical Outcomes of Intensity Modulated Proton Therapy Reirradiation for Gynecologic Malignancies

Advances in Radiation Oncology, 2023
Purpose: Pelvic reirradiation (re-RT) for patients with gynecologic cancers remains a challenge because of toxicity concerns. Given the dosimetric advantages of proton therapy, we aimed to assess oncologic and toxicity outcomes of patients with re-RT to ...
Ariel E. Pollock, MD, Hunter Risher, BS, Melanie Berger, MD, Dana M. Roque, MD, Gautam Rao, MD, Elizabeth M. Nichols, MD, Pranshu Mohindra, MD, MMM   +6 more
doaj   +1 more source

Clinical commissioning of intensity‐modulated proton therapy systems: Report of AAPM Task Group 185 [PDF]

, 2021
Proton therapy is an expanding radiotherapy modality in the United States and worldwide. With the number of proton therapy centers treating patients increasing, so does the need for consistent, high-quality clinical commissioning practices.
Daniel Yeung, X. Ronald Zhu, Lu, Hsiao Ming, Bues, Martin, Narayan Sahoo, Allgower, Chris E., Wayne D. Newhauser, Sahoo, Narayan, Roelf Slopsema, Mihailidis, Dimitris N., Hosang Jin, Michael F. Moyers, Jin, Hosang, Newhauser, Wayne D., Dimitris N. Mihailidis, Slopsema, Roelf, Martin Bues, Hsi, Wen Chien, Farr, Jonathan B., Jonathan B. Farr, Moyers, Michael F., Zhu, X. Ronald, Chris E. Allgower, Yeung, Daniel, Wen‐Chien Hsi, Hsiao‐Ming Lu   +25 more
core   +1 more source

A Systematic Review of Proton Therapy for the Management of Nasopharyngeal Cancer [PDF]

International Journal of Particle Therapy, 2021
Purpose: With improved technology, more patients with nasopharyngeal cancer (NPC) are receiving definitive treatment with proton therapy, which allows greater sparing of dose to normal tissues without compromising efficacy. As there is no randomized data,
Anna Lee, MD, MPH, Sarin Kitpanit, MD, Marina Chilov, MLS, Johannes A. Langendijk, MD, PhD, Jiade Lu, MD, MBA, Nancy Y. Lee, MD, FASTRO   +5 more
doaj   +1 more source

Post-Irradiation Sinus Mucosa Disease in Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Proton Therapy

, 2022
In the past decade, patients with nasopharyngeal cancer (NPC) have been deemed candidates for proton radiotherapy, due to the large and comprehensive target volumes and the necessity for the retention of the surrounding healthy tissues. In this study, we
Po-Hung Chang, Chien-Yu Lin, Yung-Chih Chou, Bing-Shen Huang, Yun-Shien Lee, Pei-Wen Wu, Shih-Wei Yang, Chi-Che Huang, Kang-Hsing Fan, Joseph Chang, Chien-Chia Huang, Ta-Jen Lee   +11 more
core   +1 more source

A review of proton therapy – Current status and future directions

Precision Radiation Oncology, 2022
The original rationale for proton therapy was its highly conformal depth‐dose distributions compared to photons, which allow greater sparing of normal tissues and escalation of tumor doses, thus potentially improving outcomes.
Radhe Mohan
doaj   +1 more source

A pilot study on the comparison between planning target volume-based intensity-modulated proton therapy plans and robustly optimized intensity-modulated proton therapy plans

Journal of Medical Physics, 2018
The objective of this work is to compare the planning target volume (PTV)-based intensity-modulated proton therapy (IMPT) plans with robustly optimized IMPT plans using the robust optimization tools available in Pinnacle Treatment Planning System.
Bojarajan Perumal, Harikrishna Etti Sundaresan, Ranganathan Vaitheeswaran   +2 more
doaj   +1 more source

Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness

BMC Cancer, 2021
Background Proton beam therapy (PBT) is a new-emerging cancer treatment in China but its treatment costs are high and not yet covered by Chinese public medical insurance.
Guo Li, Yun-Fei Xia, Yi-Xiang Huang, Deniz Okat, Bo Qiu, Jerome Doyen, Pierre-Yves Bondiau, Karen Benezery, Jin Gao, Chao-Nan Qian   +9 more
doaj   +1 more source

Outcomes of Proton Beam Therapy Compared With Intensity-Modulated Radiation Therapy for Uterine Cancer [PDF]

International Journal of Particle Therapy, 2022
Purpose: To compare Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in patients with endometrial cancer receiving adjuvant pelvic radiation therapy with proton beam therapy (PT) versus intensity ...
Justin D. Anderson, MD, Molly M. Voss, Brady S. Laughlin, MD, Allison E. Garda, MD, Khaled Aziz, Trey C. Mullikin, MD, Michael G. Haddock, MD, Ivy A. Petersen, MD, Todd A. DeWees, PhD, Sujay A. Vora, MD   +9 more
doaj   +1 more source

Additional file 1 of Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness

, 2021
Additional file 1: Figure S1. Markov cohort analyses. a. Cohort analysis for intensity-modulated proton radiation therapy strategy. b. Cohort analysis for intensity-modulated photon-radiation therapy strategy.
Yi-Xiang Huang (7507817), Pierre-Yves Bondiau (4023596), Guo Li (174860), Chao-Nan Qian (9035546), Jin Gao (160559), Jerome Doyen (9035540), Deniz Okat (11310208), Karen Benezery (9035543), Bo Qiu (743480), Yun-Fei Xia (248098)   +9 more
core   +1 more source